MedPath

陕西超群制药有限公司

Ownership
-
Established
2002-03-20
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

NMPA:15

Drug Approvals

Aciclovir Tablets

Product Name
阿昔洛韦片
Approval Number
国药准字H20073895
Approval Date
Mar 29, 2023
NMPA

Roxithromycin Capsules

Product Name
罗红霉素胶囊
Approval Number
国药准字H20073883
Approval Date
Mar 29, 2023
NMPA

Medical Absorbable Hemostatic Fibre

Product Name
吸收性氧化纤维素
Approval Number
国药准字H20059294
Approval Date
Mar 31, 2022
NMPA

骨刺消痛胶囊

Approval Number
国药准字Z20053342
Approval Date
Sep 17, 2020
NMPA

胃康灵胶囊

Approval Number
国药准字Z20053937
Approval Date
Sep 17, 2020
NMPA

更年安胶囊

Approval Number
国药准字Z20053247
Approval Date
Sep 17, 2020
NMPA

益肾兴阳胶囊

Approval Number
国药准字Z20043176
Approval Date
Sep 17, 2020
NMPA

消渴降糖片

Approval Number
国药准字Z20053273
Approval Date
Sep 17, 2020
NMPA

哮喘片

Approval Number
国药准字Z20054040
Approval Date
Sep 17, 2020
NMPA

脑得生片

Approval Number
国药准字Z20053348
Approval Date
Sep 17, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.